About Us

Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.

What We Do

The integumentary system is the surfaces and barriers of the human body, largely comprised of the skin. Integumen has a portfolio of products and technologies which broadly focus on applications with identified and growing markets within skincare, oral care and wound care which are either on the market or at an advanced stage of product development.

Meet the Team

Declan Service

Chief Executive Officer
Declan has over 25 years’ experience in the global medical device and pharmaceutical arena working in a wide variety of companies and disciplines with 20 of those years spent with Baxter International, Invacare and Convatec. Declan has been a director and CEO of Innovenn since April 2014. He has been CEO of Lifesciencehub since April 2011 and corporate development director of Venn Life Sciences since March 2010. Declan has experience working with innovative and dynamic start-ups, guiding them through the often challenging areas of bringing their product to market successfully. Declan has been a director and CEO of Integumen since its inception in May 2016.

Chris Bell FCA (Ireland)

Chief Financial Officer
Chris joined Integumen in September 2016 with over 25 years’ of experience in mergers and acquisitions, fundraisings and business process design. Prior to joining Integumen in 2016, Chris was Chief Financial Officer of Greenstar, one of Ireland’s largest recycling and waste-to-energy companies, with a turnover of €98 million and employing 675 staff. Previously, Chris held a number of senior finance positions in manufacturing, design and engineering companies within a range of private equity, PLC and owner-manager environments,. Chris is a Fellow of Chartered Accountants Ireland, having qualified with Pannell Kerr Forster in 1989.

The Company is organised into four divisions:
Back to Top